AlphaQuest’s Cogent Biosciences COGT Stock Holding History

AlphaQuest’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,200	Closed	-$256K	–	446
2025 Q4	$256K	Buy	7,200 +22	+0.3%	+$618	0.01%	1317
2025 Q3	$103K	Sell	7,178 -1,132	-14%	-$13.4K	0.01%	1714
2025 Q2	$59.7K	Sell	8,310 -10,440	-56%	-$57.9K	0.01%	1588
2025 Q1	$112K	Buy	18,750 +10,738	+134%	+$84.2K	0.01%	1259
2024 Q4	$62.5K	Sell	8,012 -16,970	-68%	-$169K	0.01%	1238
2024 Q3	$270K	Buy	24,982 +14,421	+137%	+$140K	0.02%	941
2024 Q2	$89K	Buy	+10,561	New	+$80.1K	0.01%	956

Other funds holding COGT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

AlphaQuest's COGT Position: Q1 2026 in Review

AlphaQuest sold out of Cogent Biosciences (COGT) in Q1 2026, closing a stake of 7,200 shares — an estimated $256K sold.

AlphaQuest first reported a position in COGT in Q2 2024 and held it in 7 quarters. The position peaked at $270K in Q3 2024. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

AlphaQuest reported no remaining Cogent Biosciences position as of Q1 2026 after selling out during the quarter.
AlphaQuest sold 7,200 Cogent Biosciences shares in Q1 2026, an estimated $256K.
AlphaQuest first reported a position in Cogent Biosciences in Q2 2024 and held it in 7 quarters.
AlphaQuest's Cogent Biosciences position peaked at $270K in Q3 2024.
305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.